Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
Intangible Assets
Pacific Biosciences of California Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
Intangible Assets
$15.1m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Intangible Assets
$15.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Danaher Corp
NYSE:DHR
|
Intangible Assets
$17.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
|
Waters Corp
NYSE:WAT
|
Intangible Assets
$558.2m
|
CAGR 3-Years
35%
|
CAGR 5-Years
17%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Intangible Assets
$426m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Intangible Assets
$5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
30%
|
|
Pacific Biosciences of California Inc
Glance View
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The company is headquartered in Menlo Park, California and currently employs 728 full-time employees. The company went IPO on 2010-10-27. The firm designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The firm has developed its Single Molecule, Real-Time (SMRT) technology, which enables single molecule, real-time detection of nucleic acid sequences, to address many of the limitations of previous sequencing technologies. The Company’s products include Sequel, Sequel II and Sequel IIe instruments and SMRT Cell 8M, which together can sequence up to approximately eight million deoxyribonucleic acid (DNA) molecules simultaneously, and the previous generation Sequel instrument and Sequel SMRT Cell 1M, which together conduct, monitor, and analyze single molecule biochemical reactions in real time. The firm's Sequel IIe System increases computational capacity and is designed to enable customers to generate PacBio HiFi reads.
See Also
What is Pacific Biosciences of California Inc's Intangible Assets?
Intangible Assets
15.1m
USD
Based on the financial report for Dec 31, 2025, Pacific Biosciences of California Inc's Intangible Assets amounts to 15.1m USD.
What is Pacific Biosciences of California Inc's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
-67%
Over the last year, the Intangible Assets growth was -96%. The average annual Intangible Assets growth rates for Pacific Biosciences of California Inc have been -67% over the past three years .
